- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05493020
The Association Between Watching Mukbang Videos and the Appetite of Children With Cancer
The Association of Mukbang Watching Behavior and the Appetite of Children With Cancer Hospitalized for Radiotherapy and Chemotherapy: An Intensive Longitudinal Study
Study Overview
Detailed Description
World Health Organization(WHO) data shows that the prevalence of malnutrition in children with cancer is as high as 75%, which leads to decreased immune function in children with cancer, unsatisfactory treatment effect, increased adverse clinical outcomes, early tumor recurrence, prolonged recovery time, and death. risk factors such as increased rates. The "Global Childhood Oncology Initiative" proposed by WHO in 2020 pointed out that reducing hunger and malnutrition and improving the outcomes of children with cancer are one of the main tasks of providing best practices in pediatric oncology care.
The excessive consumption of the body caused by the cachexia of the tumor itself cannot be changed. Nutritional intake is the only adjustable factor for malnutrition in children with tumors. Loss of appetite is the main reason for insufficient nutritional intake. Numerous clinical studies have explored the nutritional management of children with cancer. However, most nutritional interventions are ineffective due to poor appetite and food intake in children.
The investigation in the clinical ward found that in order to cope with the problem of loss of appetite, many children with cancer took the initiative to watch "Mukbang" during hospitalization to relieve gastrointestinal symptoms and increase appetite. At present, studies have shown that "Mukbang" may have the potential to improve the appetite of children with tumors. In addition, watching "Mukbang" is a way that children actively choose to increase their appetite, which has better acceptability.
Intensive longitudinal study can explain the dynamic changes of children's behavior and appetite when watching "Mukbang" videos by sampling in a natural context for a short period of time and multiple times, and based on real-time data, further Explain in detail the persistent effect of watching "Mukbang" video behaviors on appetite.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510080
- XIAW
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Aged 3-18;
- Children who conform to the Notice on Printing and Distributing the Diagnosis and Treatment Specifications for 12 Diseases Related to Hematological Diseases and Malignancies in Children (2021 Edition) issued by the General Office of the National Health and Health Commission;
- Experienced at least one complete cycle of chemotherapy and radiotherapy.
Exclusion Criteria:
- Children with severe cardiopulmonary disease, severe infection, severe organ damage, genetic metabolic disease, immunodeficiency disease or mental illness;
- Children with eye and ear dysfunction at the same time, resulting in the inability to watch and listen to videos.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Questionnaires assessed children with cancer
Children with cancer who received at least one radiotherapy and chemotherapy during hospitalization
|
At baseline, the children's demographics, disease-related data, characteristics of "Mukbang"watching behavior, appetite, nutritional status, and quality of life data were collected.
From the first day of radiotherapy or chemotherapy, 3 meals a day for 5 consecutive days were followed to track the children's appetite status and the characteristics of "Mukbang"watching behavior.
Their nutritional status and quality of life were tracked at the end of treatment or when they were discharged from the hospital.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Appetite
Time Frame: Appetite change over 5 days during chemoradiotherapy from baseline
|
The appetite will be assessed by Cancer Appetite and Symptom Questionnaire(CASQ) .
The questionnaire consisted of 12 items, each item ranged from 0 to 4 points, and the total score of the questionnaire ranged from 0 to 48 points.
The lower the total score, the worse the patient's appetite.
|
Appetite change over 5 days during chemoradiotherapy from baseline
|
|
Mukbang Watching Features
Time Frame: Mukbang Watching Features change over 5 days during chemoradiotherapy from baseline
|
The "Mukbang" watching features will be assessed by a questionnaire designed by the researcher and recorded by the subjects themselves, including watching time, watching rate, watching preferences and watching experience.
|
Mukbang Watching Features change over 5 days during chemoradiotherapy from baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Nutritional status
Time Frame: Change in nutritional status over 7 days from baseline
|
The nutritional status will be assessed by using the Subjective Global Nutritional Assessment(SGNA).
Assessment included the children's recent height, weight, parental height, dietary intake, changes in appetite, frequency and duration of gastrointestinal symptoms, and recent physical activity and changes.
This provides a comprehensive assessment of the nutritional status of children, with ratings classified as well-nourished, moderately malnourished or severely malnourished.
|
Change in nutritional status over 7 days from baseline
|
|
Quality of Life in children with cancer
Time Frame: Change in quality of life over 7 days from baseline
|
The quality of life in children with cancer will be assessed by using the Pediatric Quality of Life Inventory Measurement Models 3.0(PedsQLTM-3.0-cancer).The model has a total of 27 items, including 8 subscales, each item used a 5-point Likert scale, (0=never, 1=almost never, 2=sometimes, 3=often, 4 = almost always), higher scores indicate better quality of life.
|
Change in quality of life over 7 days from baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Wei Xia, Sun Yat-sen University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- L2022SYSU-HL-089
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mukbang
-
Cornell UniversityCompleted
-
Sun Yat-sen UniversityRecruiting
-
Sun Yat-sen UniversityRecruiting
Clinical Trials on Questionnaires set
-
Sun Yat-sen UniversityNot yet recruiting
-
The University of Hong KongCompleted
-
Sun Yat-sen UniversityRecruiting
-
The University of Hong KongCompletedHealth-Related Quality Of LifeHong Kong
-
Sun Yat-sen UniversityRecruitingSurgery | Patient With Colorectal CancerChina
-
Sun Yat-sen UniversityRecruitingRelationship, FamilyChina
-
Sun Yat-sen UniversityRecruiting
-
Kovacs FoundationCompleted
-
Kovacs FoundationTerminated
-
Sun Yat-sen UniversityNot yet recruitingSexual and Reproductive HealthChina